Trump COVID Catastrophe: Hydroxychloroquine Linked to 17,000 Deaths, Shocking Findings from French Study
“French Study Reveals Alarming Toll: Nearly 17,000 Deaths Linked to Hydroxychloroquine Prescriptions During COVID-19, Trump’s Promoted ‘Miracle’ Drug Under Scrutiny
A recent investigation by French researchers suggests that almost 17,000 individuals from six countries may have lost their lives after being prescribed hydroxychloroquine during the COVID-19 pandemic. The drug, championed by former US President Donald Trump as a cure for COVID-19, is now associated with a staggering death toll, according to the findings.
Amid the pandemic, Trump actively encouraged Americans to take hydroxychloroquine (HCQ), an anti-malaria medication also used for treating rheumatoid arthritis and lupus. He claimed to have personally used the “miracle” drug. Following the coronavirus outbreak, scientists initially proposed HCQ as a potential treatment, leading to the FDA’s emergency use authorization on March 28, 2020, and subsequent clinical trials.
While some scientists dubbed HCQ a “magic bullet” against the virus, Trump emphasized a “miracle” recovery attributed to a COVID-infected woman who used the drug. During a COVID Taskforce briefing, the former president stated, “The nice part is, it’s been around for a long time…if things don’t go as planned, it’s not going to kill anybody.” In a tweet on March 21, 2020, he lauded the FDA’s swift action, declaring the drug’s immediate use as an antidote to curb COVID transmission.”
However, by June 2020, the FDA had rescinded the emergency use authorization for the drug. This decision came in light of multiple studies, including one conducted by the New England Journal of Medicine, which indicated that hydroxychloroquine (HCQ) provided no benefits in treating COVID-19 and, in fact, posed a significant increase in the risk of death. The FDA officially revoked the emergency use authorization on June 15, 2020.
Association with Elevated Mortality Risk
A recent investigation led by French researchers suggests that almost 17,000 individuals across six countries may have succumbed to death after receiving hydroxychloroquine prescriptions while hospitalized with COVID-19 during the initial wave from March to July 2020. Published in the February edition of Biomedicine & Pharmacotherapy, the research reveals that the upsurge in deaths was linked to side effects such as heart arrhythmia and muscle weakness.
The countries included in the study were the US, Turkey, Belgium, France, Spain, and Italy.The US reported the highest death toll at 12,739, followed by Spain (1,895 deaths), Italy (1,822 deaths), Belgium (240 deaths), France (199 deaths), and Turkey (95 deaths).
The researchers conducted an analysis of various studies tracking hospitalizations due to COVID-19, drug exposure, and associated risks. They note that the actual number of deaths could be even higher, as their study focused on only six countries during the period from March to July 2020.
The aftermath of the FDA’s decision revealed a concerning trend associated with hydroxychloroquine Trump emphasized . The drug, once touted as a potential remedy for COVID-19, was now linked to an increased risk of mortality. The findings from a new study conducted by French researchers shed light on the alarming consequences of prescribing hydroxychloroquine to COVID-19 patients during the initial wave from March to July 2020.
Published in the February issue of Biomedicine & Pharmacotherapy, the research underscored that the surge in deaths was not attributable to the virus itself but rather to adverse reactions triggered by hydroxychloroquine Trump emphasized . Notably, complications such as heart arrhythmia and muscle weakness emerged as prominent contributors to the heightened mortality risk.
The countries scrutinized in the study—namely the US, Turkey, Belgium, France, Spain, and Italy—experienced varying degrees of impact. The United States reported the highest death toll at 12,739, followed by Spain with 1,895 deaths, Italy with 1,822 deaths, Belgium with 240 deaths, France with 199 deaths, and Turkey with 95 deaths.
Delving into the methodology, the researchers meticulously analyzed numerous studies that tracked hospitalizations due to COVID-19, assessing the correlation between drug exposure and the associated risks. Despite their comprehensive approach, the researchers acknowledged a potential underestimation of the death toll, as their study focused solely on six countries during the critical timeframe from March to July 2020.
This revelation added a somber layer to the hydroxychloroquine Trump emphasized narrative, challenging the initial optimism surrounding its potential as a COVID-19 treatment and prompting a reevaluation of its widespread use. The intricate interplay between science, policy, and public health had brought about a complex and consequential chapter in the ongoing battle against the pandemic.
For the latest updates-click here.